Replimune Group, Inc.
REPL · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $785 | $515 | $1,028 | $887 |
| - Cash | $111 | $74 | $147 | $106 |
| + Debt | $76 | $76 | $61 | $33 |
| Enterprise Value | $751 | $516 | $942 | $813 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$254 | -$228 | -$172 | -$114 |
| % Margin | – | – | – | – |
| Net Income | -$247 | -$216 | -$174 | -$118 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.07 | -3.24 | -2.99 | -2.26 |
| % Growth | 5.2% | -8.4% | -32.3% | – |
| Operating Cash Flow | -$192 | -$185 | -$128 | -$82 |
| Capital Expenditures | -$7 | -$6 | -$2 | -$2 |
| Free Cash Flow | -$199 | -$191 | -$130 | -$85 |